| Articles Reviewed |
| 1: | Qiaozhu Su et al. Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase. 2006 |
| 2: | Alessandra Spaziani et al. Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1. 2006 |
| 3: | Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 4: | Susana Guerra et al. Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells. 2006 |
| 5: | Stephan A Vorburger et al. Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo. 2005 |
| 6: | Pedro Gonzalez-Alegre et al. Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia. 2005 |
| 7: | Alessandro Salvi et al. Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells. 2004 |
| 8: | Richard L Bennett et al. Serine 18 phosphorylation of RAX, the PKR activator, is required for PKR activation and consequent translation inhibition. 2004 |
| 9: | Takenori Takizawa et al. Double-stranded RNA-activated protein kinase interacts with apoptosis signal-regulating kinase 1. Implications for apoptosis signaling pathways. 2002 |
| 10: | Constantinos Koumenis et al. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. 2002 |
| 11: | A H Wong et al. Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR. 2001 |
| 12: | A L Peel et al. Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue. 2001 |